Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

3048 results

Sort By:

PET/MRI in Rectal Cancer

Study ID: NCT06057831
Start Date: 2026-05
End Date: 2030-12
Study Type

Interventional

Study Phase

Phase2

No. of Participants

40

Intervention / Treatment

Total Neo-adjuvant Therapy

18FDG-PET/MRI scan

Sponsor

AHS Cancer Control Alberta

Source: clinicaltrials.gov

Share:
Add to list

Fosamprenavir for Laryngopharyngeal Upper Airway Tissue Treatment and Enzyme Reduction

Study ID: NCT04383262
Start Date: 2026-04-01
End Date: 2027-10-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

104

Intervention / Treatment

Fosamprenavir Calcium

Placebo

Sponsor

Medical College of Wisconsin

Source: clinicaltrials.gov

Share:
Add to list

Antenatal Stress and Infants In MAR

Study ID: NCT07408453
Start Date: 2026-04
End Date: 2027-09
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

100

Intervention / Treatment

Diagnostic procedures

Sponsor

IRCCS Eugenio Medea

Source: clinicaltrials.gov

Share:
Add to list

Promoting Palliative Care for People With Heart Failure

Study ID: NCT06933875
Start Date: 2026-04
End Date: 2027-08-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

2260

Intervention / Treatment

Clinical Decision Support Tool

Sponsor

Yale University

Source: clinicaltrials.gov

Share:
Add to list

Prognostic Role of Lipoprotein(a) in Elective Percutaneous Coronary Revascularization

Study ID: NCT07197242
Start Date: 2026-10-01
End Date: 2027-12-30
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

156

Intervention / Treatment
Sponsor

Assiut University

Source: clinicaltrials.gov

Share:
Add to list

Fecal MicrobiotaTransplant for the Treatment of Parkinson's Disease

Study ID: NCT06647277
Start Date: 2026-07
End Date: 2027-12
Study Type

Interventional

Study Phase

Phase1

No. of Participants

10

Intervention / Treatment

Fecal Microbiota Transplant

Sponsor

ProgenaBiome

Source: clinicaltrials.gov

Share:
Add to list

Phase II Study Assessing the Safety and Efficacy of Dasatinib in Combination With Ropeginterferon in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase

Study ID: NCT07269470
Start Date: 2026-05-01
End Date: 2029-11-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

40

Intervention / Treatment

Dasatinib

Ropeginterferon alfa-2b (P1101)

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Cessation or Reduction of Alcohol Consumption in Veterans: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate the Efficacy and Safety of a GLP-1 Receptor Agonist Semaglutide in U.S. Veterans With Alcohol Use Disorder

Study ID: NCT07218354
Start Date: 2026-05-01
End Date: 2029-05-26
Study Type

Interventional

Study Phase

Phase3

No. of Participants

438

Intervention / Treatment

Semaglutide

Placebo

Sponsor

VA Office of Research and Development

Source: clinicaltrials.gov

Share:
Add to list

The Comparison of Ibandronate and Zoledronic Acid After Denosumab Discontinuation

Study ID: NCT07406685
Start Date: 2026-03-17
End Date: 2030-09-17
Study Type

Interventional

Study Phase

Phase4

No. of Participants

52

Intervention / Treatment

Ibandronate IV

Zoledronic acid IV

Sponsor

National Taiwan University Hospital

Source: clinicaltrials.gov

Share:
Add to list

Pregnenolone as a Treatment for Cannabis Intoxication

Study ID: NCT07216690
Start Date: 2026-04-01
End Date: 2029-01-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

20

Intervention / Treatment

Cannabis

Pregnenolone 250 mg

Pregnenolone 500 mg

Placebo

Placebo brownies

Sponsor

Johns Hopkins University

Source: clinicaltrials.gov

Share:
Add to list